自动胰岛素输注:获益、挑战与推荐——欧洲糖尿病研究协会与美国糖尿病协会糖尿病技术联合工作组共识报告
该共识报告由欧洲糖尿病研究协会与美国糖尿病协会糖尿病技术联合工作组制定,综述自动胰岛素输注(AID)系统的当前格局并重点关注安全性,最后给出一系列推荐的针对性行动。这是该工作组系列报告的第四份,工作组由两组织执行机构联合委托成立。
要点
- 连续血糖监测的可靠性推动胰岛素泵可根据传感器血糖数据调节输注。
- 首批自动胰岛素输注系统已获监管批准并进入临床实践。
- 1型糖尿病社区已用独立商用产品自建自助式自动胰岛素输注系统。
核心结论
- 工作组对自动胰岛素输注系统的当前格局进行综述并重点关注其安全性,最后给出一系列推荐的针对性行动。
研究设计与样本
- 该共识报告由欧洲糖尿病研究协会与美国糖尿病协会的糖尿病技术联合工作组制定。
- 工作组由两组织执行机构联合委托成立,最初撰写组由美国糖尿病协会提名的3名成员与欧洲糖尿病研究协会提名的3名成员组成。
- 后续为增加多样性与专业范围补充了作者,两组织对每篇稿件在提交期刊编辑审稿前均提供了类似的内部审查流程。
- 这是该工作组系列报告中的第四份,工作组选择每份声明的主题并提交两组织确认。
主要发现
- 过去10年可整合入临床诊疗的设备大幅增长。
- 由连续血糖监测可靠系统的可及性驱动,已进入可通过胰岛素泵依据传感器血糖数据调节胰岛素输注的时代。
- 过去几年首批自动胰岛素输注系统已获监管批准并被纳入临床诊疗。
- 1型糖尿病社区人群通过使用供独立使用的商业化产品,以自助方式自建了系统。
- 多种自动胰岛素输注系统正在开发中,其中部分预计在不久的将来获得监管批准。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A technological solution for the management of diabetes in people who require intensive insulin therapy has been sought for decades. The last 10 years have seen substantial growth in devices that can be integrated into clinical care. Driven by the availability of reliable systems for continuous glucose monitoring, we have entered an era in which insulin delivery through insulin pumps can be modulated based on sensor glucose data. Over the past few years, regulatory approval of the first automated insulin delivery (AID) systems has been granted, and these systems have been adopted into clinical care. Additionally, a community of people living with type 1 diabetes has created its own systems using a do-it-yourself approach by using products commercialised for independent use. With several AID systems in development, some of which are anticipated to be granted regulatory approval in the near future, the joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association has created this consensus report. We provide a review of the current landscape of AID systems, with a particular focus on their safety. We conclude with a series of recommended targeted actions. This is the fourth in a series of reports issued by this working group. The working group was jointly commissioned by the executives of both organisations to write the first statement on insulin pumps, which was published in 2015. The original authoring group was comprised by three nominated members of the American Diabetes Association and three nominated members of the European Association for the Study of Diabetes. Additional authors have been added to the group to increase diversity and range of expertise. Each organisation has provided a similar internal review process for each manuscript prior to submission for editorial review by the two journals. Harmonisation of editorial and substantial modifications has occurred at both levels. The members of the group have selected the subject of each statement and submitted the selection to both organisations for confirmation.
引用
- Sherr JL, Heinemann L, Fleming GA, et al. Automated insulin delivery: benefits, challenges, and recommendations. A Consensus Report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association. Diabetologia. 2022. PMID: 36198829. doi:10.1007/s00125-022-05744-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。